The Claim
Thyroid epithelial cells in autoimmune thyroid disease exhibit upregulated expression of complement pathway genes, contributing to local immune activation and tissue damage in MHCII-positive thyrocytes.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In autoimmune thyroid disease, thyroid cells increase the activity of complement pathway genes, leading to immune activation and tissue damage in cells that display MHCII molecules.
See the scientific wording
Thyroid epithelial cells in autoimmune thyroid disease upregulate complement pathway genes, which may contribute to local immune activation and tissue damage, as observed in MHCII-positive thyrocytes.
Thyroid cells that display MHCII molecules turn on genes that produce complement proteins, which attract immune cells and trigger inflammation, leading to destruction of thyroid tissue.
What the research says
1 studyStudy: MON-425 Defining Disease-Specific Epithelial Cell Phenotypes in Thyroid Autoimmunity
In people with autoimmune thyroid disease, some thyroid cells start acting like immune cells and turn on genes that help attack invaders — including a system called the complement system that can cause inflammation and damage. This study found that these weird thyroid cells are the same ones that display MHC class II molecules, proving they’re involved in triggering local immune attacks.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.